Fishers Innovation in Biopharma Manufacturing

Scroll Down

Indiana is an attractive potential location for new and growing biopharma manufacturing companies, boasting low facility operating costs, access to highly-educated candidates, and funding opportunities.

In this article, Mayor Scott Fadness explores the benefits that Fishers, a part of the Indianapolis metropolitan area, has to offer biopharma CDMOs. He also highlights the potential for companies already established in the area, like Genezen, to expand, leading to new jobs and fostering growth in the region’s biotech hub.

Read the full article here: Fishers Innovation in Biopharma Manufacturing

You may also be interested in...

Genezen appoints Chief Commercial Officer to…

  Genezen, a cell and gene therapy Contract Development and Manufacturing...

Read more

Downstream Process Development for Lentiviral Vectors…

Lentiviral vectors (LVV) are commonly used as an efficient and safe...

Read more

Stable cell lines vs transient transfection…

The aim of upstream processing in viral vector development and manufacturing...

Read more

Genezen delivers next phase of cGMP…

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization...

Read more